Comparative effectiveness over time of the mRNA-1273 (Moderna) | ResearchBunny

Index

Abstract

This retrospective cohort study compared the effectiveness of mRNA-1273 (Moderna) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 infection in over 3.5 million fully vaccinated individuals. The study found that mRNA-1273 offered slightly more protection against infection than BNT162b2, reaching statistical significance at 90 days post-vaccination. However, no difference was observed in protection against hospitalization, ICU admission, or death between the two vaccines.

Publisher

Nature Communications

Published On

Nov 16, 2022

Authors

Nazmul Islam, Natalie E. Sheils, Megan S. Jarvis, Kenneth Cohen

Related Publications

Explore these studies to deepen your understanding of the subject.

Medicine and Health

The BNT162b2 mRNA COVID-19 Vaccine Increases the Contractile Sensitivity to Histamine and Parasympathetic Activation in a Human Ex Vivo Model of Severe Eosinophilic Asthma

A. Caputo, F. Nicoli, et al.

Medicine and Health

BNT162b2 mRNA vaccine elicited antibody response in blood and milk of breastfeeding women

M. Rosenberg-friedman, A. Kigel, et al.

The Arts

Monsters revisited: a comparative study of the use of humor in dramatizing benevolent monsters in *The Monsters under the Bed* and *The Boy Who Loved Monsters and the Girl Who Loved Peas*

H. M. Bayoumy

Biology

Neuroimaging the effects of smartphone (over-)use on brain function and structure-a review on the current state of MRI-based findings and a roadmap for future research

C. Montag and B. Becker

Listen, Learn & Level Up

Over 10,000 hours of research content in 25+ fields, available in 12+ languages.

No more digging through PDFs—just hit play and absorb the world's latest research in your language, on your time.

listen to research audio papers with researchbunny